Prescription Required.Why?
A sodium-glucose co-transporter 2 (sglt2) inhibitor.
A dipeptidyl peptidase-4 (dpp-4) inhibitor.
Treatment of type 2 diabetes mellitus in adults to improve glycemic control when metformin alone is insufficient.
May be used in combination with other diabetes medications as determined by a healthcare professional.
Dapagliflozin works by preventing the kidneys from reabsorbing glucose, increasing its excretion in the urine. Teneligliptin enhances the release of insulin from the pancreas in response to rising blood glucose levels and reduces glucagon secretion, thereby improving glycemic control.
Store at room temperature (20-25°C), away from direct sunlight and moisture. Keep out of reach of children.
Dosage should be determined by a healthcare professional based on individual needs and response to treatment.
Typically administered once daily, with or without food.
Urinary tract infections
Increased urination (especially at night)
Dehydration
Yeast infections (vulvovaginal candidiasis)
Hyperkalemia (elevated potassium levels)
Hypotension (low blood pressure)
Nausea
Vomiting
Constipation
Headache
Dizziness
Moderate alcohol consumption should be discussed with your doctor. Excessive alcohol can exacerbate some side effects.
May cause dizziness or hypotension, caution is advised.
Use is generally not recommended during pregnancy and breastfeeding. Consult your doctor.
Not indicated for use in children.
Renal function should be monitored, dose adjustment may be necessary in patients with kidney impairment.
Liver function should be considered, dose adjustment may be necessary in patients with severe liver impairment.
Consult the official prescribing information provided by the manufacturer.
Your doctor or pharmacist can provide additional information.
